Lisata Therapeutics and Kuva Labs agreed to extend the deadline to commence a tender offer under their merger agreement from April 3, 2026, to April 13, 2026.
Key takeaways
The parties executed a waiver to extend the tender offer commencement date by ten days, moving the deadline from April 3, 2026, to April 13, 2026.
The extension modifies the original Agreement and Plan of Merger dated March 6, 2026, specifically adjusting the timeline in Section 1.1(a).
The waiver extends the commencement period to 26 Business Days after the Merger Agreement date, up from the original 20 Business Days.
All other terms and conditions of the Merger Agreement remain unchanged and in full force.